Of this evaluation. In addition, there are actually findings from lower-evidence research on further second-generation antipsychotics (clozapine, quetiapine, risperidone), mood stabilisers (divalproex-extended release, lithium, oxcarbazepine), antidepressants (MAOI tranylcypromine, NRI reboxetine,…